FOZZA, Claudio
 Distribuzione geografica
Continente #
NA - Nord America 3.004
EU - Europa 1.640
AS - Asia 885
SA - Sud America 28
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 8
Totale 5.574
Nazione #
US - Stati Uniti d'America 2.987
UA - Ucraina 645
CN - Cina 593
IT - Italia 288
DE - Germania 275
SG - Singapore 214
SE - Svezia 192
FI - Finlandia 87
GB - Regno Unito 50
CZ - Repubblica Ceca 28
BE - Belgio 26
BR - Brasile 24
KR - Corea 24
FR - Francia 23
CA - Canada 17
TR - Turchia 17
IR - Iran 10
AU - Australia 8
IN - India 8
EU - Europa 7
ES - Italia 4
HK - Hong Kong 4
SA - Arabia Saudita 4
CH - Svizzera 3
PL - Polonia 3
AE - Emirati Arabi Uniti 2
AR - Argentina 2
AT - Austria 2
BD - Bangladesh 2
GR - Grecia 2
JP - Giappone 2
NL - Olanda 2
RO - Romania 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AZ - Azerbaigian 1
CL - Cile 1
EE - Estonia 1
HU - Ungheria 1
IE - Irlanda 1
IL - Israele 1
JO - Giordania 1
LT - Lituania 1
LV - Lettonia 1
MD - Moldavia 1
MN - Mongolia 1
MT - Malta 1
NZ - Nuova Zelanda 1
RU - Federazione Russa 1
TH - Thailandia 1
VE - Venezuela 1
Totale 5.574
Città #
Chandler 882
Jacksonville 386
Princeton 246
Nanjing 155
Singapore 150
Dearborn 119
Wilmington 107
Ann Arbor 86
Sassari 86
New York 85
Beijing 63
Boardman 60
Nanchang 52
Shenyang 42
Hebei 34
Tianjin 34
Jiaxing 31
Ashburn 29
Santa Clara 29
Changsha 27
Brussels 26
Mountain View 26
Woodbridge 26
Andover 24
Seoul 24
Zhengzhou 24
Jinan 21
Brno 20
Taubaté 20
San Francisco 16
Falls Church 15
Kunming 15
Hangzhou 14
Munich 14
Izmir 13
Norwalk 13
Dallas 12
Helsinki 12
Ningbo 12
Toronto 12
San Mateo 11
Shanghai 10
Guangzhou 9
Cagliari 8
Los Angeles 8
Taizhou 8
Ardabil 7
Gossolengo 7
Haikou 7
Olomouc 7
Rome 7
Albiate 6
Auburn Hills 6
St Louis 6
Houston 5
Monmouth Junction 5
Quartu Sant'elena 5
Romola 5
Chicago 4
Florence 4
Lanzhou 4
Riyadh 4
Canberra 3
Desio 3
Fuzhou 3
Leipzig 3
Magdeburg 3
Melbourne 3
Nuremberg 3
Nürnberg 3
Redwood City 3
Rudolfstetten 3
Seattle 3
Tappahannock 3
Washington 3
Augusta 2
Bologna 2
Cabras 2
Carpino 2
Dubai 2
Frankfurt am Main 2
Hanover 2
Kochi 2
Leawood 2
London 2
Markham 2
Milan 2
Mönchengladbach 2
Philadelphia 2
Rho 2
Sabz 2
São Paulo 2
Taiyuan 2
Tokyo 2
Valencia 2
Vienna 2
Warsaw 2
Wuxi 2
Albany 1
Almere Stad 1
Totale 3.292
Nome #
Acute basophilic leukemia with U2AF1 mutation 99
A case of coexistence between JAK2V617F and BCR/ABL 86
Epstein–Barr virus infection is associated to patients with multiple myeloma and monoclonal gammopathy of undetermined significance 76
A genome-wide association study by ImmunoChip reveals potential modifiers in myelodysplastic syndromes 71
Different graphene oxide flakes dimensions impact on whole gene expression and molecular interactions in immune cells 70
Glucose-6-phosphate dehydrogenase deficiency and risk of invasive fungal disease in patients with acute myeloid leukemia 69
Strategie di sorveglianza attiva e networking per il controllo delle infezioni da L. monocytogenes 69
Azacitidine improves the T-cell repertoire in patients with myelodysplastic syndromes and acute myeloid leukemia with multilineage dysplasia 68
Keratitis-Ichthyosis-Deafness Syndrome, Atypical Connexin GJB2 Gene Mutation, and Peripheral T-Cell Lymphoma: More Than a Random Association? 68
Fludarabine and Cytarabine Combination in the Induction of Adult Patients with Acute Myeloid Leukaemia 67
Acute lymphoblastic leukemia in a nine-year-old girl with isodicentric chromosome 15 syndrome 67
Adult T-cell acute lymphoblastic leukemia: biologic profile at presentation and correlation with response to induction treatment in patients enrolled in the GIMEMA LAL 0496 protocol 65
Long-lasting fever of unknown origin preceding the diagnosis of intravascular lymphomatosis: a further case stimulates some remarks 64
Few-Layer Graphene Kills Selectively Tumor Cells from Myelomonocytic Leukemia Patients 64
Two cases of chronic lymphoproliferative disorders in psoriatic patients treated with cyclosporine: hairy cell leukemia and Waldenstrom macroglobulinemia 63
The role of Clofarabine in the treatment of adults with Acute Myeloid Leukemia 63
Isolated polyglobulia as an uncommon presentation of chronic myeloid leukaemia 63
Safe fluoroquinolones prophylaxis in blood cancer patients with chemotherapy-induced neutropenia and Glucose-6-Phosphate-Dehydrogenase deficiency 63
Study of the T-cell receptor repertoire by CDR3 spectratyping 62
Evidence of a skewed T-cell repertoire in patients with light chain amyloidosis 61
Arterial occlusive events in chronic myeloid leukemia patients treated with ponatinib in the real-life practice are predicted by the Systematic Coronary Risk Evaluation (SCORE) chart 60
Molecular and Genomic Impact of Large and Small Lateral Dimension Graphene Oxide Sheets on Human Immune Cells from Healthy Donors 59
Telomere length shortening is associated with treatment-free remission in chronic myeloid leukemia patients 59
A case-report of a pulmonary tuberculosis with lymphadenopathy mimicking a lymphoma 59
Pregnancy Outcome among Women with Beta-Thalassemia Major in North Sardinia 57
T-cell receptor repertoire usage in hematologic malignancies 56
The role of T-cells in the pathogenesis of myelodysplastic syndromes: Passengers and drivers 56
Primary extranodal vaginal non-hodgkin lymphoma: Diagnostic pitfalls and therapeutic challenges 55
Rhino-maxillary and orbital mucormycosis in a patient with acute myeloid leukaemia:a successful surgery and antifungal therapy combined approach 55
Azacitidine improves the T-cell repertoire in patients with myelodysplastic syndromes and acute myeloid leukemia with multilineage dysplasia 55
Strabismus and diplopia in a patient with acute myeloid leukemia 54
Therapy-Related Myeloid Neoplasms: Report Of The Italian Network On Secondary Leukemias. 54
T-cell receptor repertoire kinetic during azacitidine treatment. 54
Retuning the immune system in myelodysplastic syndromes: from immunomodulatory approaches to vaccination strategies and non myeloablative hemopoietic cell transplant 54
Characteristics and outcome of therapy-related myeloid neoplasms: Report from the Italian network on secondary leukemias 54
Total antioxidant capacity in Mediterranean β-thalassemic patients 53
Improved Outcome with ATRA-Arsenic Trioxide Compared to ATRA-Chemotherapy in Non-High Risk Acute Promyelocytic Leukemia – Updated Results of the Italian-German APL0406 Trial on the Extended Final Series. 52
The immune landscape of myelodysplastic syndromes 52
Correlation of Oxidative Stress Biomarkers and Hematological Parameters in Blood Cancer Patients from Sardinia, Italy 52
Breakthrough cutaneous alternariosis in a patient with acute lymphoblastic leukemia: clinical features and diagnostic issues 52
Acquired hemophilia in a patient affected by acute myeloid leukemia 51
Are T-cell dysfunctions the other side of the moon in the pathogenesis of myelodysplastic syndromes? 51
Flow cytometry assessment of CD26+ leukemic stem cells in peripheral blood: A simple and rapid new diagnostic tool for chronic myeloid leukemia 51
Antiproliferative and proapoptotic effects of Inula viscosa extract on Burkitt lymphoma cell line. 51
Regulatory T cells in stem cell transplantation: Main characters or walk-on actors? 50
Asymptomatic cardiac lymphoma in a hepatitis C virus-positive thalassemic patient 50
The burden of autoimmunity in myelodysplastic syndromes 50
Factors for graft-versus-host disease after donor lymphocyte infusions with an escalating dose regimen: lack of association with cell dose 49
T-cell receptor repertoire kinetic during azacitidine treatment. 48
Cardiovascular toxicity in patients with chronic myeloid leukemia treated with second-generation tyrosine kinase inhibitors in the real-life practice: Identification of risk factors and the role of prophylaxis 48
Efficacy of rituximab in autoimmune hemolytic anemia associated with splenic marginal zone lymphoma 48
Disease relapse after haematopoietic stem cell transplantation: Risk factors and treatment 47
Anaplastic large cell lymphoma of the breast arising around mammary implant capsule: an italian report. 47
T-cell receptor repertoire usage after allografting differs between CD4+CD25+ regulatory T cells and their CD4+CD25- counterpart 47
CD4+ and CD8+ T-Cell Skewness in Classic Kaposi Sarcoma 45
Patients with myelodysplastic syndromes show reduced frequencies of CD4(+) CD8(+) double-positive T cells 45
T-cell receptor repertoire kinetic during azacitidine treatment. 45
Low low-density lipoprotein (LDL), cholesterol and triglycerides plasma levels are associated with reduced risk of arterial occlusive events in chronic myeloid leukemia patients treated with ponatinib in the real-life. A Campus CML study 45
A Sequential use of TKI, chemotherpay and transplant is associated with high complete remission rates, DFS and OS in adult PH+ ALL. Results of the GIMEMA 0904 protocol. 45
Remembering Professor Maurizio Longinotti Obituary 44
Increased Frequency of Immune Thrombocytopenic Purpura in Coeliac Disease and Vice Versa: a prospective observational study 44
dic(14;14)(p11.1;p11.1) in paziente con sindrome mielodisplastica 43
Patients with myelodysplastic syndromes show reduced frequencies of CD4+CD8+ double positive T-cells 43
A novel pattern of uridine diphosphate glucuronosyltransferase polymorphisms associated with hyperbilirubinemia during nilotinib treatment 43
Levels and Clinical Significance of Regulatory B Cells and T Cells in Acute Myeloid Leukemia 43
Derangement of the T-cell repertoire in patients with B-cell non-Hodgkin's lymphoma 43
Response to donor lymphocyte infusions for chronic myeloid leukemia is dose-dependent: the importance of escalating the cell dose to maximize therapeutic efficacy 42
Rituximab maintenance or retreatment after autologous transplantation for relapsed follicular lymphoma? 42
Cytogenetic and hematological spontaneous remission in a case of acute myelogenous leukemia 42
Prompt recovery of chemotherapy associated Hand-Foot syndrome treated with acetylsalicylic acid in two patients with Hodgkin's lymphoma 41
Long-term mortality rate for cardiovascular disease in 656 chronic myeloid leukaemia patients treated with second- and third-generation tyrosine kinase inhibitors 41
Renin angiotensin system inhibitors reduce the incidence of arterial thrombotic events in patients with hypertension and chronic myeloid leukemia treated with second- or third-generation tyrosine kinase inhibitors 41
T-cell receptor repertoire analysis in monozygotic twins concordant and discordant for type 1 diabetes 41
Large B-cell non-Hodgkin lymphoma relapsing with meningeal localization 40
High frequency of the TCRBV20S1 null allele in the Sardinian population 40
A real-world study on clofarabine and cytarabine combination in patients with relapsed/refractory acute myeloid leukemia 40
T-Cell Traffic Jam in Hodgkin's Lymphoma: Pathogenetic and Therapeutic Implications 39
Managing chronic myeloid leukemia for treatment-free remission: a proposal from the GIMEMA CML WP 39
TCRBV20S1 polymorphism does not influence the susceptibility to type 1 diabetes and multiple sclerosis in the Sardinian population 39
Assessment of Bone Metabolism Alterations in Transfusion-dependent Beta-thalassemia Major 39
T-cell receptor repertoire in healthy Sardinian subjects 39
UMBALANCED REARRANGEMENT DER(9;18)(P10;Q10) AND JAK2 V617F MUTATION IN A PATIENT WITH AML FOLLOWING POST-POLYCYTHEMIC MYELOFIBROSIS 39
Syk kinase inhibitors synergize with artemisinins by enhancing oxidative stress in plasmodium falciparum-parasitized erythrocytes 38
Gene expression profiling identifies a subset of adult T-cell acute lymphoblastic leukemia with myeloid-like gene features and over-expression of miR-223 37
Patients with early stage myelodysplastic syndromes show increased frequency of CD4+CD25high+CD127low regulatory T-cells 37
Improved Outcomes With Retinoic Acid and Arsenic Trioxide Compared With Retinoic Acid and Chemotherapy in Non-High-Risk Acute Promyelocytic Leukemia: Final Results of the Randomized Italian-German APL0406 Trial 36
MicroRNA-181a-3p as a Diagnostic and Prognostic Biomarker for Acute Myeloid Leukemia 36
White Blood Cell Count Nadir and Duration of Aplasia Do Not Associate with Treatment Outcome in Adult Patients with Acute Myeloid Leukemia Undergoing Intensive Chemotherapy 36
Patients with myelodysplastic syndromes display several T-cell expansions, which are mostly polyclonal in the CD4(+) subset and oligoclonal in the CD8(+) subset 35
Hematological, biochemical and antioxidant indices variations in regular blood donors among Mediterranean regions 35
Patients with early stage myelodysplastic syndromes show increased frequency of CD4+CD25high+CD127low regulatory T-cells. 34
Use of rituximab in autoimmune hemolytic anemia associated with non-hodgkin lymphomas 34
Deciphering the prognostic significance of autoimmune disorders in myelodysplastic syndromes 34
Clarifying the molecular mechanism of tomentosin‑induced antiproliferative and proapoptotic effects in human multiple myeloma via gene expression profile and genetic interaction network analysis 33
Rectal involvement in pre-early T acute lymphoblastic leukemia 32
Dramatic erythroid response to low-dose Thalidomide in two patients with transfusion independent thalassemia and severe post-transfusional alloimmune haemolysis 31
Favourable outcome of chronic myeloid leukemia co-expressing e13a2 and e14a2 transcripts, treated with nilotinib 31
Incidence and evaluation of predisposition to cardiovascular toxicity in chronic myeloid leukemia patients treated with bosutinib in the real-life practice 31
Recurrent arterial occlusive events in patients with chronic myeloid leukemia treated with second- and third-generation tyrosine kinase inhibitors and role of secondary prevention 31
Low-density lipoprotein (LDL) levels and risk of arterial occlusive events in chronic myeloid leukemia patients treated with nilotinib 30
Totale 4.951
Categoria #
all - tutte 31.488
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 31.488


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020734 0 0 0 16 101 110 193 13 112 49 134 6
2020/2021936 117 6 150 12 117 41 126 5 145 139 61 17
2021/2022621 67 5 3 13 9 17 35 49 47 40 78 258
2022/20231.556 149 123 65 265 157 242 5 164 267 13 63 43
2023/2024471 78 40 14 20 98 47 11 17 0 5 40 101
2024/2025384 34 39 242 69 0 0 0 0 0 0 0 0
Totale 5.745